PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF THE BISPECIFIC T-CELL ENGAGER ANTIBODY BLINATUMOMAB IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA

被引：0
|
作者：
Hijazi, Y. [1 ]
Klinger, M. [1 ]
Schub, A. [1 ]
Wu, B. [2 ]
Zhu, M. [2 ]
Kufer, P. [1 ]
Wolf, A. [1 ]
Nagors-en, D. [3 ]
机构：
[1] Amgen Res Munich GmbH, Munich, Germany
[2] Pharmacokinet & Drug Metab, Thousand Oaks, CA USA
[3] Amgen Inc, Clin Dev, Thousand Oaks, CA 91320 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P306
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [21] Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma
    Viardot, Andreas
    Goebeler, Marie-Elisabeth
    Hess, Georg
    Neumann, Svenja
    Pfreundschuh, Michael
    Adrian, Nicole
    Zettl, Florian
    Libicher, Martin
    Sayehli, Cyrus
    Stieglmaier, Julia
    Zhang, Alicia
    Nagorsen, Dirk
    Bargou, Ralf C.
    BLOOD, 2016, 127 (11) : 1410 - 1416
  • [22] Blinatumomab: A novel, bispecific, T-cell engaging antibody
    May, Megan Brafford
    Glode, Ashley
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (01) : E6 - E13
  • [23] Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma
    Fozza, Claudio
    Corda, Giovanna
    Virdis, Patrizia
    Contini, Salvatore
    Barraqueddu, Francesca
    Galleu, Antonio
    Isoni, Antonella
    Cossu, Antonella
    Dore, Fausto
    Careddu, Maria G.
    Bonfigli, Silvana
    Giannico, Barbara
    Longinotti, Maurizio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (04) : 298 - 309
  • [24] Management of patients with non-Hodgkin's lymphoma: focus on adoptive T-cell therapy
    Perna, Serena Kimi
    Huye, Leslie E.
    Savoldo, Barbara
    IMMUNOTARGETS AND THERAPY, 2015, 4 : 55 - 63
  • [25] Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma
    Blosser, Nikki
    Jupp, Jennifer
    Yau, Patrick
    Stewart, Douglas
    CLINICAL PHARMACOKINETICS, 2020, 59 (01) : 7 - 23
  • [26] Anaplastic, T-cell, non-Hodgkin's lymphoma presenting with haematuria
    Blick, C.
    Abdelhadi, S.
    Bailey, D.
    Muneer, A.
    THESCIENTIFICWORLDJOURNAL, 2008, 8 : 342 - 345
  • [27] Primary T-cell non-Hodgkin's malignant lymphoma of the appendix
    Kitamura, Y
    Ohta, T
    Terada, T
    PATHOLOGY INTERNATIONAL, 2000, 50 (04) : 313 - 317
  • [28] Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma
    Nikki Blosser
    Jennifer Jupp
    Patrick Yau
    Douglas Stewart
    Clinical Pharmacokinetics, 2020, 59 : 7 - 23
  • [29] Increased radiosensitivity in a child with T-cell non-Hodgkin's lymphoma
    AttardMontalto, SP
    Saha, V
    Kingston, J
    Plowman, N
    Taylor, M
    Arlett, C
    Bridges, B
    Eden, O
    MEDICAL AND PEDIATRIC ONCOLOGY, 1996, 27 (06): : 565 - 570
  • [30] Cytotoxic T-cell non-hodgkin's lymphoma of the thyroid gland
    Okamoto, A
    Namura, K
    Uchiyama, H
    Kajita, Y
    Inaba, T
    Nakamura, S
    Shimazaki, C
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (01) : 77 - 78
12345